Gene · 722
Papers2,921
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,921
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The impact of PROS1 mutation position on thrombotic risk in protein S-deficient patients. | Res Pract Thromb Haemost | 2023 | 37384225 | PubTator, text mining | PubMed |
| Conformational dynamics of complement protease C1r inhibitor proteins from Lyme disease- and relapsing fever-causing spirochetes. | J Biol Chem | 2023 | 37380082 | PubTator, text mining | PubMed |
| Complement Activation-Independent Attenuation of SARS-CoV-2 Infection by C1q and C4b-Binding Protein. | Viruses | 2023 | 37376569 | PubTator, text mining | PubMed |
| 3D Bioprinting of Hyaline Articular Cartilage: Biopolymers, Hydrogels, and Bioinks. | Polymers (Basel) | 2023 | 37376340 | PubTator, text mining | PubMed |
| Protein Corona Attenuates the Targeting of Antitumor Sialyl Lewis X-Decorated Liposomes to Vascular Endothelial Cells under Flow Conditions. | Pharmaceutics | 2023 | 37376203 | PubTator, text mining | PubMed |
| Adult-Onset Linear Morphea (en coupe de sabre) of the Face Successfully Treated with Photoactivated Low-Temperature Platelet-Rich Plasma: A Valid Therapeutic Option. | Medicina (Kaunas) | 2023 | 37374318 | PubTator, text mining | PubMed |
| Dysregulation of Immune Cell Subpopulations in Atypical Hemolytic Uremic Syndrome. | Int J Mol Sci | 2023 | 37373158 | PubTator, text mining | PubMed |
Analysis of Plasma Proteins Involved in Inflammation, Immune Response/Complement System, and Blood Coagulation upon Admission of COVID-19 Patients to Hospital May Help to Predict the Prognosis of the Disease. | Cells | 2023 | 37371071 | PubTator, text mining | PubMed |
| Heme Interactions as Regulators of the Alternative Pathway Complement Responses and Implications for Heme-Associated Pathologies. | Curr Issues Mol Biol | 2023 | 37367079 | PubTator, text mining | PubMed |
| Novel vs. modified platelet-rich plasma therapy for hair loss treatment: a systematic review and meta-analysis. | Ann Med Surg (Lond) | 2023 | 37363595 | PubTator, text mining | PubMed |
| The role of WNT and IL-1 signaling in osteoarthritis: therapeutic implications for platelet-rich plasma therapy. | Front Aging | 2023 | 37362206 | PubTator, text mining | PubMed |
| Complement system in Anti-CD20 mAb therapy for cancer: A mini-review. | Int J Immunopathol Pharmacol | 2023 | 37357623 | PubTator, text mining | PubMed |
| Physical and chemical properties of saliva and its role in Early Childhood caries - A systematic review and meta-analysis. | J Oral Biol Craniofac Res | 2023 | 37351419 | PubTator, text mining | PubMed |
| Proteomic-based identification of APCS as candidate protein for diagnosis of patients exhibiting anti-tubercular drug induced liver injury. | Sci Rep | 2023 | 37349331 | PubTator, text mining | PubMed |
| Antibody- and aptamer-free SERS substrate for ultrasensitive and anti-interference detection of SARS-CoV-2 spike protein in untreated saliva. | Biosens Bioelectron | 2023 | 37321043 | PubTator, text mining | PubMed |
| DiLeu Isobaric Labeling Coupled with Limited Proteolysis Mass Spectrometry for High-Throughput Profiling of Protein Structural Changes in Alzheimer's Disease. | Anal Chem | 2023 | 37307028 | PubTator, text mining | PubMed |
| Interactions between the lung microbiome and host immunity in chronic obstructive pulmonary disease. | Chronic Dis Transl Med | 2023 | 37305112 | PubTator, text mining | PubMed |
| Identification of potential biomarkers to predict organ morbidity in COVID-19: A repository based proteomics perspective. | Biochem Biophys Rep | 2023 | 37304132 | PubTator, text mining | PubMed |
| Molecular Signatures in Swine Innate and Adaptive Immune Responses to African Swine Fever Virus Antigens p30/p54/CD2v Expressed Using a Highly Efficient Semliki Forest Virus Replicon System. | Int J Mol Sci | 2023 | 37298266 | PubTator, text mining | PubMed |
| Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing. | Front Immunol | 2023 | 37287976 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/722/papers?page=13